Fort Washington Investment Advisors Inc. OH Boosts Position in Maximus, Inc. $MMS

Fort Washington Investment Advisors Inc. OH boosted its holdings in Maximus, Inc. (NYSE:MMS) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 343,727 shares of the health services provider’s stock after purchasing an additional 14,180 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned about 0.63% of Maximus worth $29,671,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in MMS. Deprince Race & Zollo Inc. grew its position in shares of Maximus by 147.1% in the 3rd quarter. Deprince Race & Zollo Inc. now owns 243,695 shares of the health services provider’s stock valued at $22,266,000 after buying an additional 145,062 shares during the last quarter. Boston Partners lifted its position in Maximus by 113.6% in the second quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after acquiring an additional 349,529 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Maximus by 19.8% in the third quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock valued at $18,304,000 after acquiring an additional 33,136 shares during the last quarter. Stephens Investment Management Group LLC boosted its stake in Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after acquiring an additional 237,097 shares in the last quarter. Finally, Divisadero Street Capital Management LP grew its holdings in shares of Maximus by 93.5% during the third quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock worth $16,800,000 after purchasing an additional 88,872 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Maximus

In related news, CFO David Mutryn acquired 1,000 shares of the firm’s stock in a transaction on Monday, February 9th. The stock was bought at an average cost of $75.62 per share, with a total value of $75,620.00. Following the transaction, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. The trade was a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Bruce Caswell bought 3,175 shares of the stock in a transaction on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the purchase, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. The trade was a 0.98% increase in their position. The SEC filing for this purchase provides additional information. 1.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on MMS. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Weiss Ratings downgraded Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Maximus Stock Down 1.5%

Shares of NYSE:MMS opened at $65.05 on Friday. Maximus, Inc. has a 1-year low of $64.66 and a 1-year high of $100.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. The stock has a market cap of $3.55 billion, a P/E ratio of 9.90 and a beta of 0.59. The firm has a fifty day moving average price of $79.22 and a 200 day moving average price of $84.33.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the previous year, the business posted $1.61 earnings per share. Maximus’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.33 dividend. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 2.0%. Maximus’s payout ratio is presently 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.